This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Critical Care/ Intensive Care Medicine  • Adult Critical Care  • Genetics, Other  • Alert me on articles by topic

Tracy Hampton, PhD

JAMA. 2004;291:287-288.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Washington—An intensive care unit (ICU), often charged with a sense of urgency, may seem worlds removed from functional genomics, the research-centered field that seeks to discover how genes and their products work individually and together. But scientists and physicians at a recent conference argued that knowledge of human responses to injury and infection at the molecular level might greatly improve critical care medicine.

At the second annual symposium on "Functional Genomics of Critical Illness and Injury" held at the National Institutes of Health headquarters in Bethesda, Md, the discussion began with how to move forward to apply the wealth of genetic information flowing from the recently completed human genome project to the clinic. Research is revealing that much can be gained from understanding the genetic basis of a patient's response to therapy.

A microarray determining which of thousands of genes in leukemia cells were expressed . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Emerging Concepts in Nutrigenomics: A Preview of What Is to Come
Kauwell
Nutr Clin Pract 2005;20:75-87.
ABSTRACT | FULL TEXT